ANTI-FUNGAL
Consistent
Purity
Global-Ready
Molecules
Advanced
Manufacturing
Scalable
Production
Partnership
Support
Ciclopirox API has been developed by ASANA Pharmaceutical as part of its dermatological and anti-infective portfolio. Ciclopirox API, identified by CAS number 29342-05-0, is a broad-spectrum antifungal agent commonly used in the treatment of superficial fungal infections affecting skin, nails, and scalp.
ASANA Pharmaceutical is engaged in the development and manufacturing of high-quality antifungal APIs, including Ciclopirox. With a focus on topical and dermatological applications, ASANA ensures every batch meets international safety and efficacy standards. Operating across North America, Europe, and Asia, the company supports global partners with consistent supply, regulatory support, and quality-driven production systems.
ASANA Pharmaceutical maintains strong collaboration with formulation developers, clinical researchers, and quality assurance experts to advance therapies in the dermatology and anti-infective space. Ciclopirox [CAS No. 29342-05-0] is a broad-spectrum antifungal agent used to treat skin, nail, and scalp infections caused by fungi and yeast. It plays a key role in ASANA’s topical API portfolio designed for targeted treatment and high patient compliance. As the need for effective antifungal therapies continues to grow, ASANA remains committed to delivering:
Ciclopirox API are available on public databases such as Wikipidia!